Privi Speciality Chemicals Ltd

  • BSE Code : 530117
  • NSE Symbol : PRIVISCL
  • ISIN : INE959A01019
  • Industry :CHEMICALS

up-arrow 2,941.10 10.10(0.34%)

Open Price ()

2,929.90

Prev. Close ()

2,931.00

Volume (No’s)

75,207

Market Cap ()

11,488.73

Low Price ()

2,865.70

High Price ()

2,962.80

 

Board Meetings

Start Date End Date Purpose
29-Jan-2026 09-Feb-2026 Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve Intimation of Board Meeting to be held on Monday February 092026 to consider and approve the un-audited standalone and consolidated financials results. Outcome of Board Meeting held on February 09, 2026 pursuant to Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (As per BSE Announcement dated on: 09.02.2026)
19-Dec-2025 19-Dec-2025 Outcome of Board Meeting held on December 19,2025 to consider and approve scheme of amalgamation.
15-Nov-2025 15-Nov-2025 Outcome of the Board Meeting held on November 15,2025 for withdrawal of the application under regulation 37 of SEBI (LODR) Regulations, 2015 for obtaining NOC from Stock Exchanges in respect of proposed Scheme of Amalgamation.
29-Oct-2025 05-Nov-2025 Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 ,inter alia, to consider and approve the un-audited standalone and consolidated Financial Results for the quarter and half year ended September 30,2025 Outcome of the Board Meeting held on November 05,2025 for declaration of Unaudited standalone and cosolidated financial results of the company for the quarter and half year ended September 30,2025 Un-audited Financial Results for the quarter and half year ended September 30,2025 (As Per BSE Announcement Dated on:05.11.2025)
22-Jul-2025 01-Aug-2025 Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 inter alia to consider and approve To Consider and approve the Un-audited Standalone and Financial Results for the quarter ended on June 302025 Outcome of the the Board Meeting held on August 01,2025 to consider and approve Unaudited standalone and consolidated financial results of the company for the quarter ended June 30,2025. (As Per BSE Announcement Dated on: 01.08.2025)

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew